Barrio, Francisco Boutriau, Dominique Cabanillas, Lucia Caubet, Magalie Centeno, Fernando De Torres, Maria Jose Espín, José Esporrin, Carlos García-Sicilia, José Merino, José Manuel Mesaros, Narcisa Miller, Jacqueline M Moreno-Pérez, David Moro, Manuel Muro, Marta Navarro, Maria-Luisa Omeñaca, Félix Ruiz-Contreras, Jesús Ruiz Contreras, Jesús
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. [artículo] - The Pediatric infectious disease journal, 2012 2012 - 31(10):1074-7.
Formato Vancouver:
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F et al. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia
J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M,
Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Five-year
antibody persistence and safety following a booster dose of combined Haemophilus
influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Contiene 19 referencias
BACKGROUND: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been reported to induce different MenC antibody responses depending on the priming vaccines, with a possible impact on long-term protection. Here, the five-year persistence of immune responses induced by a booster dose of Hib-MenC-TT was evaluated in toddlers primed with either Hib-MenC-TT or MenC-TT.
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. [artículo] - The Pediatric infectious disease journal, 2012 2012 - 31(10):1074-7.
Formato Vancouver:
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F et al. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia
J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M,
Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Five-year
antibody persistence and safety following a booster dose of combined Haemophilus
influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Contiene 19 referencias
BACKGROUND: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been reported to induce different MenC antibody responses depending on the priming vaccines, with a possible impact on long-term protection. Here, the five-year persistence of immune responses induced by a booster dose of Hib-MenC-TT was evaluated in toddlers primed with either Hib-MenC-TT or MenC-TT.
